Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ARG1 inhibitors(Arginase-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | PL | 01 Jan 2024 | |
Endothelial dysfunction | Preclinical | PL | 01 Jan 2024 | |
Pulmonary Arterial Hypertension | Preclinical | PL | 01 Jan 2024 | |
Reperfusion Injury | Preclinical | PL | 01 Jan 2024 |